Compare OVID & CINT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OVID | CINT |
|---|---|---|
| Founded | 2014 | 1995 |
| Country | United States | Brazil |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 522.6M | 478.1M |
| IPO Year | 2017 | 2021 |
| Metric | OVID | CINT |
|---|---|---|
| Price | $2.52 | $4.23 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 5 | 6 |
| Target Price | $4.60 | ★ $7.35 |
| AVG Volume (30 Days) | ★ 1.8M | 163.6K |
| Earning Date | 05-13-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 3.90 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $7,252,000.00 | N/A |
| Revenue This Year | N/A | $16.69 |
| Revenue Next Year | $19.34 | $11.28 |
| P/E Ratio | ★ N/A | $17.94 |
| Revenue Growth | ★ 1181.27 | N/A |
| 52 Week Low | $0.27 | $3.16 |
| 52 Week High | $3.11 | $6.11 |
| Indicator | OVID | CINT |
|---|---|---|
| Relative Strength Index (RSI) | 45.92 | 59.82 |
| Support Level | $2.33 | $4.03 |
| Resistance Level | $2.72 | $5.01 |
| Average True Range (ATR) | 0.16 | 0.24 |
| MACD | -0.01 | 0.10 |
| Stochastic Oscillator | 32.46 | 97.30 |
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.
CI&T Inc operates as a partner in tech-integrated business solutions, helping organizations address complex challenges by integrating business approach, technology, and artificial intelligence into a single, coherent operating model. It is mainly engaged in the development of customizable software through the implementation of software solutions, including machine learning, artificial intelligence, data analytics, cloud migration and mobility technologies. The company provides technology services to various industry verticals, including Financial Services, Consumer Goods, Technology and Communications, Retail and Industrial Goods, Life Sciences, among others. The majority of the revenue is derived from providing technology services. Geographically, maximum revenue is derived from Brazil.